Faisal G. Sukhtian
Independent Chairman of the BoardMr. Faisal G. Sukhtian is Director of Expert Petroleum SRL. Mr. Sukhtian has been a Director of Outlook Therapeutics, Inc. since September 11, 2017 and also serves as Chairman of the Board Since January 31, 2025. He has been the chairman of the board of Genepharm, a leading European B2B pharmaceutical company, since 2019. Mr. Sukhthian is a Director of MS Pharma. He has served as a Director of GMS Tenshi Holdings Pte. Limited since 2011 and an Executive Director of GMS Holdings, a diversified investment company, since 2008. In addition to managing operations of GMS Holdings, Mr. Sukhtian oversees a number of investments within the GMS Holdings portfolio and serves as a director of GMS Holdingsâ board of directors. From 2008 to 2011, Mr. Sukhtian served as Executive Director of Munir Sukhtian International. From 2010 to 2011, he served as Managing Director of Agri Sciences Ltd., an agrochemicals manufacturing business based in Turkey. Mr. Sukhtian has served as a Director of BioLexis Private Limited since 2011. He has served as a member of the board of directors of Expert Petroleum, an oilfield services company based in Romania, since 2008, Agri Sciences since 2010, MS Pharma, a leading MENA based branded pharmaceutical generics company, since 2011 and Stelis Biopharma Private Limited, a biotherapeutic and biosimilar developer and manufacturer based in India, since 2015 to 2021. Mr. Sukhtian served as a member of the board of directors of Alvogen from 2008 to 2014 and Waterloo Industries, Inc. from 2015 to 2017. Mr. Sukhtian worked at JP Morgan, in New York, where he worked primarily on mergers and acquisitions, debt and equity transactions serving clients in the industrials and transportation industries. Mr. Sukhtian is designated to the Board by GMS Ventures pursuant to the Amended and Restated Investor Rights Agreement by and between Outlook Therapeutics, Inc. and GMS Ventures dated April 21, 2022. Mr. Sukhtian received an M.B.A. from Columbia Business School and a B.S. in International Economics from Georgetown University’s School of Foreign Service.
Positions
- Company NameOutlook Therapeutics, Inc.Stock CodeOTLKPositionIndependent Chairman of the BoardColleagues
- RCRobert Charles JahrPresident, CEO & Director
- KLKevin LundquistCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- JPJoel PrieveSenior Vice President of Licensing and M&A
- SSSurendra SharmaSenior Vice President of Medical Affairs
- JMJennifer M. KissnerSenior Vice President of Clinical Development & Regulatory Affairs
- KJKurt J. HilzingerIndependent Director
- RHRalph H. ThurmanLead Independent Director
- YMYezan M. HaddadinIndependent Director
